These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 27129682

  • 1. Development of a Plasmodium berghei transgenic parasite expressing the full-length Plasmodium vivax circumsporozoite VK247 protein for testing vaccine efficacy in a murine model.
    Mizutani M, Fukumoto S, Soubeiga AP, Soga A, Iyori M, Yoshida S.
    Malar J; 2016 Apr 30; 15(1):251. PubMed ID: 27129682
    [Abstract] [Full Text] [Related]

  • 2. A universal vaccine candidate against Plasmodium vivax malaria confers protective immunity against the three PvCSP alleles.
    Gimenez AM, Salman AM, Marques RF, López-Camacho C, Harrison K, Kim YC, Janse CJ, Soares IS, Reyes-Sandoval A.
    Sci Rep; 2021 Sep 09; 11(1):17928. PubMed ID: 34504134
    [Abstract] [Full Text] [Related]

  • 3. Chimeric Plasmodium falciparum parasites expressing Plasmodium vivax circumsporozoite protein fail to produce salivary gland sporozoites.
    Marin-Mogollon C, van Pul FJA, Miyazaki S, Imai T, Ramesar J, Salman AM, Winkel BMF, Othman AS, Kroeze H, Chevalley-Maurel S, Reyes-Sandoval A, Roestenberg M, Franke-Fayard B, Janse CJ, Khan SM.
    Malar J; 2018 Aug 09; 17(1):288. PubMed ID: 30092798
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Protective efficacy of peptides from Plasmodium vivax circumsporozoite protein.
    Atcheson E, Reyes-Sandoval A.
    Vaccine; 2020 Jun 02; 38(27):4346-4354. PubMed ID: 32402755
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Baculovirus-vectored multistage Plasmodium vivax vaccine induces both protective and transmission-blocking immunities against transgenic rodent malaria parasites.
    Mizutani M, Iyori M, Blagborough AM, Fukumoto S, Funatsu T, Sinden RE, Yoshida S.
    Infect Immun; 2014 Oct 02; 82(10):4348-57. PubMed ID: 25092912
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A two-dose viral-vectored Plasmodium vivax multistage vaccine confers durable protection and transmission-blockade in a pre-clinical study.
    Yamamoto Y, Fabbri C, Okuhara D, Takagi R, Kawabata Y, Katayama T, Iyori M, Hasyim AA, Sakamoto A, Mizukami H, Shida H, Lopes S, Yoshida S.
    Front Immunol; 2024 Oct 02; 15():1372584. PubMed ID: 38745665
    [Abstract] [Full Text] [Related]

  • 12. Vaccine Containing the Three Allelic Variants of the Plasmodium vivax Circumsporozoite Antigen Induces Protection in Mice after Challenge with a Transgenic Rodent Malaria Parasite.
    Gimenez AM, Lima LC, Françoso KS, Denapoli PMA, Panatieri R, Bargieri DY, Thiberge JM, Andolina C, Nosten F, Renia L, Nussenzweig RS, Nussenzweig V, Amino R, Rodrigues MM, Soares IS.
    Front Immunol; 2017 Oct 02; 8():1275. PubMed ID: 29075260
    [Abstract] [Full Text] [Related]

  • 13. Generation of a Genetically Modified Chimeric Plasmodium falciparum Parasite Expressing Plasmodium vivax Circumsporozoite Protein for Malaria Vaccine Development.
    Miyazaki Y, Marin-Mogollon C, Imai T, Mendes AM, van der Laak R, Sturm A, Geurten FJA, Miyazaki S, Chevalley-Maurel S, Ramesar J, Kolli SK, Kroeze H, van Schuijlenburg R, Salman AM, Wilder BK, Reyes-Sandoval A, Dechering KJ, Prudêncio M, Janse CJ, Khan SM, Franke-Fayard B.
    Front Cell Infect Microbiol; 2020 Oct 02; 10():591046. PubMed ID: 33392104
    [Abstract] [Full Text] [Related]

  • 14. Population genetic structure of the Plasmodium vivax circumsporozoite protein (Pvcsp) in Sri Lanka.
    Dias S, Wickramarachchi T, Sahabandu I, Escalante AA, Udagama PV.
    Gene; 2013 Apr 15; 518(2):381-7. PubMed ID: 23333606
    [Abstract] [Full Text] [Related]

  • 15. A Multistage Formulation Based on Full-Length CSP and AMA-1 Ectodomain of Plasmodium vivax Induces High Antibody Titers and T-cells and Partially Protects Mice Challenged with a Transgenic Plasmodium berghei Parasite.
    Lima LC, Marques RF, Gimenez AM, Françoso KS, Aliprandini E, Camargo TM, Aguiar ACC, Pereira DB, Renia L, Amino R, Soares IS.
    Microorganisms; 2020 Jun 17; 8(6):. PubMed ID: 32560380
    [Abstract] [Full Text] [Related]

  • 16. Tailoring a Plasmodium vivax Vaccine To Enhance Efficacy through a Combination of a CSP Virus-Like Particle and TRAP Viral Vectors.
    Atcheson E, Bauza K, Salman AM, Alves E, Blight J, Viveros-Sandoval ME, Janse CJ, Khan SM, Hill AVS, Reyes-Sandoval A.
    Infect Immun; 2018 Sep 17; 86(9):. PubMed ID: 29986894
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A novel chimeric Plasmodium vivax circumsporozoite protein induces biologically functional antibodies that recognize both VK210 and VK247 sporozoites.
    Yadava A, Sattabongkot J, Washington MA, Ware LA, Majam V, Zheng H, Kumar S, Ockenhouse CF.
    Infect Immun; 2007 Mar 17; 75(3):1177-85. PubMed ID: 17158893
    [Abstract] [Full Text] [Related]

  • 20. Functional Conservation of P48/45 Proteins in the Transmission Stages of Plasmodium vivax (Human Malaria Parasite) and P. berghei (Murine Malaria Parasite).
    Cao Y, Hart RJ, Bansal GP, Kumar N.
    mBio; 2018 Sep 04; 9(5):. PubMed ID: 30181253
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.